Valuation : CSPC Pharmaceutical Group Limited

Market Cap 111B 14.12B 12.12B 11.37B 10.39B 19.6B 1,347B 19.7B 135B 52.16B 679B 53.01B 51.86B 2,250B P/E 2026 *
10.8x
P/E 2027 * 16x
Enterprise Value 99.86B 12.74B 10.93B 10.26B 9.37B 17.69B 1,215B 17.77B 121B 47.07B 613B 47.83B 46.79B 2,030B EV / Sales 2026 *
2.59x
EV / Sales 2027 * 2.71x
Free-Float
67.42%
Yield 2026 *
4.74%
Yield 2027 * 3.8%
1 day+1.63%
1 week+1.68%
Current month+12.82%
1 month+16.63%
3 months+37.50%
6 months-2.22%
Current year+14.83%
1 week 9.02
Extreme 9.015
9.98
1 month 8.21
Extreme 8.21
10.17
Current year 6.53
Extreme 6.53
10.96
1 year 6.53
Extreme 6.53
11.63
3 years 4.27
Extreme 4.27
11.63
5 years 4.27
Extreme 4.27
11.63
10 years 3.87
Extreme 3.86979
13.93
Manager TitleAgeSince
Chief Executive Officer 46 19/12/2025
Chief Operating Officer 56 19/12/2025
Corporate Officer/Principal 44 01/07/2024
Director TitleAgeSince
Chairman 72 26/08/2011
Director/Board Member 56 20/01/2012
Director/Board Member 66 21/12/2012
Date Insider Type Main position Quantity % Market Cap.
6/23/26 A Other

Director

-700,000 0.0061%
12/23/25 A Other

Chairman

6,706,000 0.0582%
11/25/25 A Other

Chairman

10,300,000 0.0894%
Change 5-day change 1-year change 3-year change Capi.($)
+1.63%+1.68%-0.41%+64.07% 13.89B
-0.69%-5.26%+60.59%+112.84% 1,060B
-2.03%-1.18%+49.45%+60.82% 651B
-1.78%-1.54%+23.90%+74.86% 465B
-1.62%-2.56%+37.97%+39.80% 365B
-2.15%-1.44%+22.10%+37.65% 300B
-1.30%+0.33%+1.84%+11.90% 258B
-0.57%+0.67%+51.62%+70.19% 238B
-3.47%-0.78%-17.62%-54.55% 210B
-0.74%+2.69%+29.30%+91.20% 184B
Average -1.27%+0.37%+25.87%+50.88% 374.43B
Weighted average by Cap. -1.45%-2.11%+38.04%+65.64%

Financials

2026 *2027 *
Net sales 38.62B 4.93B 4.23B 3.97B 3.63B 6.84B 470B 6.87B 46.97B 18.2B 237B 18.5B 18.1B 785B 35.63B 4.55B 3.9B 3.66B 3.34B 6.31B 434B 6.34B 43.33B 16.79B 219B 17.07B 16.7B 724B
Net income 10.12B 1.29B 1.11B 1.04B 950M 1.79B 123B 1.8B 12.31B 4.77B 62.13B 4.85B 4.74B 206B 6.98B 891M 764M 718M 655M 1.24B 84.95B 1.24B 8.49B 3.29B 42.86B 3.34B 3.27B 142B
Net Debt -10.82B -1.38B -1.18B -1.11B -1.02B -1.92B -132B -1.93B -13.15B -5.1B -66.39B -5.18B -5.07B -220B -14.06B -1.79B -1.54B -1.44B -1.32B -2.49B -171B -2.5B -17.1B -6.63B -86.3B -6.73B -6.59B -286B
Logo CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.
Employees
18,626
Date Price Change Volume
27/08/26 HK$9.680 +1.63% 121,784,743
26/08/26 HK$9.525 +1.22% 190,279,844
25/08/26 HK$9.410 +0.16% 126,608,259
24/08/26 HK$9.395 +2.23% 141,570,805
21/08/26 HK$9.190 -3.47% 135,368,018
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
9.525HKD
Average target price
12.44HKD
Spread / Average Target
+30.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1093 Stock